Clinical Trial Detail

NCT ID NCT02539459
Title Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Fox Chase Cancer Center
Indications
Therapies

Everolimus

Age Groups: adult

No variant requirements are available.